These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24823497)

  • 1. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
    Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
    J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
    Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
    Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
    Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
    J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
    Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M
    J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
    Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
    J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.
    Cam M; Durieu E; Bodin M; Manousopoulou A; Koslowski S; Vasylieva N; Barnych B; Hammock BD; Bohl B; Koch P; Omori C; Yamamoto K; Hata S; Suzuki T; Karg F; Gizzi P; Erakovic Haber V; Bencetic Mihaljevic V; Tavcar B; Portelius E; Pannee J; Blennow K; Zetterberg H; Garbis SD; Auvray P; Gerber H; Fraering J; Fraering PC; Meijer L
    J Alzheimers Dis; 2018; 62(4):1663-1681. PubMed ID: 29504531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures.
    Fu L; Sun Y; Guo Y; Chen Y; Yu B; Zhang H; Wu J; Yu X; Kong W; Wu H
    J Pept Sci; 2017 Mar; 23(3):245-251. PubMed ID: 28211253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
    Jäkel L; Boche D; Nicoll JAR; Verbeek MM
    Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.
    Ruiz-Riquelme A; Mao A; Barghash MM; Lau HHC; Stuart E; Kovacs GG; Nilsson KPR; Fraser PE; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2021 May; 9(1):83. PubMed ID: 33971978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Aβ43 deposition patterns in the brains of aged dogs, sea lions, and cats.
    Takahashi K; Chambers JK; Takaichi Y; Uchida K
    J Vet Med Sci; 2022 Nov; 84(12):1563-1573. PubMed ID: 36288928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
    Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
    Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
    Sandebring A; Welander H; Winblad B; Graff C; Tjernberg LO
    PLoS One; 2013; 8(2):e55847. PubMed ID: 23409063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
    Hemming ML; Selkoe DJ; Farris W
    Neurobiol Dis; 2007 Apr; 26(1):273-81. PubMed ID: 17321748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
    Hemming ML; Selkoe DJ
    J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
    Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
    Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
    J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
    Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO
    J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.